TERT and neoplasm: Specifically, TERT promoter mutations were significantly associated with older patient age (P < 0.001), larger tumor size (P < 0.001), capsular invasion (P < 0.001), extrathyroidal invasion (P < 0.001), advanced disease stage (P = 0.003), and higher MAICS score (P < 0.001).